Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 3.000%10/1
-
Market price (% of par)
-
54.23%
-
Total 13F principal
-
$150,514,494
-
Principal change
-
-$19,820,160
-
Total reported market value
-
$93,853,240
-
Number of holders
-
11
-
Value change
-
-$11,660,030,655
-
Number of buys
-
2
-
Number of sells
-
3
Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q1 2024
As of 31 Mar 2024,
KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 was held by
11 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$150,514,494
in principal (par value) of the bond.
The largest 10 bondholders included
BRAIDWELL LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Davidson Kempner Capital Management LP, CAPSTONE INVESTMENT ADVISORS, LLC, Birch Grove Capital LP, DeepCurrents Investment Group LLC, LAZARD ASSET MANAGEMENT LLC, Verition Fund Management LLC, BLB&B Advisors, LLC, and JPMORGAN CHASE & CO.
This page lists
11
institutional bondholders reporting positions
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.